FAKTOR-OPTIONSSCHEIN - QUEST DIAGNOSTICS | Real-time Bid/Ask 07:36:48 11/06/2024 pm IST | ||
| 6.84 EUR / 6.96 EUR | +2.68% |
|
| Current month | -1.47% | ||
| 1 month | -13.07% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 11/24/11 | 6.8 | +1.19% |
| 10/24/10 | 6.72 | +5.16% |
| 07/24/07 | 6.39 | +1.27% |
| 06/24/06 | 6.31 | +1.12% |
| 05/24/05 | 6.24 | -4.73% |
Delayed Quote Börse Stuttgart
Last update June 11, 2024 at 06:08 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | MG3D87 |
| ISIN | DE000MG3D874 |
| Date issued | 30/04/2024 |
| Strike | 165.1 $ |
| Maturity | Unlimited |
| Parity | 3.3 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.99 € |
|---|---|
| Lowest since issue | 5.76 € |
| Spread | 0.19 € |
| Spread % | 2.73% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.5
USD
Average target price
147
USD
Spread / Average Target
+3.91%
- Stock Market
- Certificates
- Certificat
